What is and what should never be#: Use and misuse of HPV testing in cervical cancer prevention strategies

Carlo A. Liverania, Paolo Vercellini, Maria P. Frattaruolo, Giorgio Bolis

Research output: Contribution to journalArticle

Abstract

The purpose of a cervical screening program is to reduce morbidity and mortality from invasive cervical cancer. High-risk HPV DNA testing is more sensitive but less specific than conventional cytology. The increase in sensitivity results in doubling of positive subjects compared with Pap smear. However, low- grade epithelial anomalies are over-represented when using HPV testing. Investigation and eventual treatment of many self-limiting conditions that would regress spontaneously result in needless psychological morbidity and increased costs. The same holds true for false positive results caused by a reduction in specificity. Moreover, the difference in sensitivity in favour of HPV testing has been demonstrated mainly at single testing. However, performance of repeated Pap smears at pre-determined time intervals greatly improves the accuracy of cytology. Limited adherence to prevention programs of women in lower socio-economic strata is among the risks related to the increase in cost of screening. The widespread utilization of different molecular tests not applied consistently according to the rules of good scientific practice has an economic, social, and psychological impact that seems to have greatly outweighed benefits. Indeed, a true reduction in mortality from invasive cervical cancer after the introduction of HPV testing has not yet been demonstrated. In addition, there is no general agreement on appropriate triage test for a positive HPV result, and guidelines are often not followed in general practice. Inappropriate testing increases costs without benefit, and potentially results in overtreatment. In European countries as well as in those countries where infrastructures are available, cytology is likely to remain the most cost-effective strategy in cervical cancer prevention, together with the implementation of HPV vaccination programs.

Original languageEnglish
Pages (from-to)113-119
Number of pages7
JournalCurrent Women's Health Reviews
Volume10
Issue number2
Publication statusPublished - 2014

Fingerprint

Uterine Cervical Neoplasms
Cell Biology
Papanicolaou Test
Costs and Cost Analysis
Economics
Psychology
Morbidity
Mortality
Triage
General Practice
Cost-Benefit Analysis
Vaccination
Guidelines
DNA
Therapeutics
Medical Overuse

Keywords

  • Cervical cancer
  • Colposcopy
  • HPV vaccine
  • Human papillomavirus
  • Screening

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

What is and what should never be# : Use and misuse of HPV testing in cervical cancer prevention strategies. / Liverania, Carlo A.; Vercellini, Paolo; Frattaruolo, Maria P.; Bolis, Giorgio.

In: Current Women's Health Reviews, Vol. 10, No. 2, 2014, p. 113-119.

Research output: Contribution to journalArticle

Liverania, Carlo A. ; Vercellini, Paolo ; Frattaruolo, Maria P. ; Bolis, Giorgio. / What is and what should never be# : Use and misuse of HPV testing in cervical cancer prevention strategies. In: Current Women's Health Reviews. 2014 ; Vol. 10, No. 2. pp. 113-119.
@article{b664291736ec4b9a947c822bb9c985f4,
title = "What is and what should never be#: Use and misuse of HPV testing in cervical cancer prevention strategies",
abstract = "The purpose of a cervical screening program is to reduce morbidity and mortality from invasive cervical cancer. High-risk HPV DNA testing is more sensitive but less specific than conventional cytology. The increase in sensitivity results in doubling of positive subjects compared with Pap smear. However, low- grade epithelial anomalies are over-represented when using HPV testing. Investigation and eventual treatment of many self-limiting conditions that would regress spontaneously result in needless psychological morbidity and increased costs. The same holds true for false positive results caused by a reduction in specificity. Moreover, the difference in sensitivity in favour of HPV testing has been demonstrated mainly at single testing. However, performance of repeated Pap smears at pre-determined time intervals greatly improves the accuracy of cytology. Limited adherence to prevention programs of women in lower socio-economic strata is among the risks related to the increase in cost of screening. The widespread utilization of different molecular tests not applied consistently according to the rules of good scientific practice has an economic, social, and psychological impact that seems to have greatly outweighed benefits. Indeed, a true reduction in mortality from invasive cervical cancer after the introduction of HPV testing has not yet been demonstrated. In addition, there is no general agreement on appropriate triage test for a positive HPV result, and guidelines are often not followed in general practice. Inappropriate testing increases costs without benefit, and potentially results in overtreatment. In European countries as well as in those countries where infrastructures are available, cytology is likely to remain the most cost-effective strategy in cervical cancer prevention, together with the implementation of HPV vaccination programs.",
keywords = "Cervical cancer, Colposcopy, HPV vaccine, Human papillomavirus, Screening",
author = "Liverania, {Carlo A.} and Paolo Vercellini and Frattaruolo, {Maria P.} and Giorgio Bolis",
year = "2014",
language = "English",
volume = "10",
pages = "113--119",
journal = "Current Women's Health Reviews",
issn = "1573-4048",
publisher = "Bentham Science Publishers B.V.",
number = "2",

}

TY - JOUR

T1 - What is and what should never be#

T2 - Use and misuse of HPV testing in cervical cancer prevention strategies

AU - Liverania, Carlo A.

AU - Vercellini, Paolo

AU - Frattaruolo, Maria P.

AU - Bolis, Giorgio

PY - 2014

Y1 - 2014

N2 - The purpose of a cervical screening program is to reduce morbidity and mortality from invasive cervical cancer. High-risk HPV DNA testing is more sensitive but less specific than conventional cytology. The increase in sensitivity results in doubling of positive subjects compared with Pap smear. However, low- grade epithelial anomalies are over-represented when using HPV testing. Investigation and eventual treatment of many self-limiting conditions that would regress spontaneously result in needless psychological morbidity and increased costs. The same holds true for false positive results caused by a reduction in specificity. Moreover, the difference in sensitivity in favour of HPV testing has been demonstrated mainly at single testing. However, performance of repeated Pap smears at pre-determined time intervals greatly improves the accuracy of cytology. Limited adherence to prevention programs of women in lower socio-economic strata is among the risks related to the increase in cost of screening. The widespread utilization of different molecular tests not applied consistently according to the rules of good scientific practice has an economic, social, and psychological impact that seems to have greatly outweighed benefits. Indeed, a true reduction in mortality from invasive cervical cancer after the introduction of HPV testing has not yet been demonstrated. In addition, there is no general agreement on appropriate triage test for a positive HPV result, and guidelines are often not followed in general practice. Inappropriate testing increases costs without benefit, and potentially results in overtreatment. In European countries as well as in those countries where infrastructures are available, cytology is likely to remain the most cost-effective strategy in cervical cancer prevention, together with the implementation of HPV vaccination programs.

AB - The purpose of a cervical screening program is to reduce morbidity and mortality from invasive cervical cancer. High-risk HPV DNA testing is more sensitive but less specific than conventional cytology. The increase in sensitivity results in doubling of positive subjects compared with Pap smear. However, low- grade epithelial anomalies are over-represented when using HPV testing. Investigation and eventual treatment of many self-limiting conditions that would regress spontaneously result in needless psychological morbidity and increased costs. The same holds true for false positive results caused by a reduction in specificity. Moreover, the difference in sensitivity in favour of HPV testing has been demonstrated mainly at single testing. However, performance of repeated Pap smears at pre-determined time intervals greatly improves the accuracy of cytology. Limited adherence to prevention programs of women in lower socio-economic strata is among the risks related to the increase in cost of screening. The widespread utilization of different molecular tests not applied consistently according to the rules of good scientific practice has an economic, social, and psychological impact that seems to have greatly outweighed benefits. Indeed, a true reduction in mortality from invasive cervical cancer after the introduction of HPV testing has not yet been demonstrated. In addition, there is no general agreement on appropriate triage test for a positive HPV result, and guidelines are often not followed in general practice. Inappropriate testing increases costs without benefit, and potentially results in overtreatment. In European countries as well as in those countries where infrastructures are available, cytology is likely to remain the most cost-effective strategy in cervical cancer prevention, together with the implementation of HPV vaccination programs.

KW - Cervical cancer

KW - Colposcopy

KW - HPV vaccine

KW - Human papillomavirus

KW - Screening

UR - http://www.scopus.com/inward/record.url?scp=84930899384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930899384&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84930899384

VL - 10

SP - 113

EP - 119

JO - Current Women's Health Reviews

JF - Current Women's Health Reviews

SN - 1573-4048

IS - 2

ER -